193 related articles for article (PubMed ID: 12390475)
1. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin.
Murohisa G; Kobayashi Y; Kawasaki T; Nakamura S; Nakamura H
Liver; 2002 Oct; 22(5):394-403. PubMed ID: 12390475
[TBL] [Abstract][Full Text] [Related]
2. Ethanol feeding enhances inflammatory cytokine expression in lipopolysaccharide-induced hepatitis.
Pennington HL; Hall PM; Wilce PA; Worrall S
J Gastroenterol Hepatol; 1997 Apr; 12(4):305-13. PubMed ID: 9195371
[TBL] [Abstract][Full Text] [Related]
3. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
[TBL] [Abstract][Full Text] [Related]
5. Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats.
Sakaguchi T; Nakamura S; Suzuki S; Oda T; Ichiyama A; Baba S; Okamoto T
Hepatology; 1999 Oct; 30(4):959-67. PubMed ID: 10498648
[TBL] [Abstract][Full Text] [Related]
6. Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration.
Pearson JM; Bailie MB; Fink GD; Roth RA
Toxicology; 1997 Sep; 121(3):181-9. PubMed ID: 9231696
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet-activating factor in pathogenesis of galactosamine-lipopolysaccharide-induced liver injury.
Komatsu Y; Shiratori Y; Hikiba Y; Hashimoto N; Han K; Kawase T; Yoshida H; Okano K; Omata M
Dig Dis Sci; 1996 May; 41(5):1030-7. PubMed ID: 8625746
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats.
Yamaguchi Y; Matsumura F; Liang J; Okabe K; Matsuda T; Ohshiro H; Ishihara K; Akizuki E; Yamada S; Ogawa M
Pancreas; 1999 May; 18(4):355-63. PubMed ID: 10231840
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of caspases in vivo protects the rat liver against alcohol-induced sensitization to bacterial lipopolysaccharide.
Deaciuc IV; D'Souza NB; de Villiers WJ; Burikhanov R; Sarphie TG; Hill DB; McClain CJ
Alcohol Clin Exp Res; 2001 Jun; 25(6):935-43. PubMed ID: 11410731
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin induced hepatic necrosis in rats on an alcohol diet.
Bhagwandeen BS; Apte M; Manwarring L; Dickeson J
J Pathol; 1987 May; 152(1):47-53. PubMed ID: 3305847
[TBL] [Abstract][Full Text] [Related]
12. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion.
Suzuki S; Serizawa A; Sakaguchi T; Tsuchiya Y; Kojima Y; Okamoto K; Kurachi K; Konno H; Fujise Y; Baba S; Nakamura S
Transplantation; 2000 Jun; 69(11):2267-73. PubMed ID: 10868624
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Fas antigen and Fas ligand in acute liver injury induced by carbon tetrachloride in rat].
Wen T; Ren F; Liu Y; Wu ZM; Zhao JY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Jul; 18(7):417-20. PubMed ID: 16831245
[TBL] [Abstract][Full Text] [Related]
14. Ethanol-altered liver-associated T cells mediate liver injury in rats administered Concanavalin A (Con A) or lipopolysaccharide (LPS).
Cao Q; Batey R; Pang G; Clancy R
Alcohol Clin Exp Res; 1999 Oct; 23(10):1660-7. PubMed ID: 10549999
[TBL] [Abstract][Full Text] [Related]
15. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
Tukov FF; Luyendyk JP; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue.
Nishiyama R; Nakamura S; Suzuki S; Baba S
Transplantation; 1993 Jun; 55(6):1261-5. PubMed ID: 8516812
[TBL] [Abstract][Full Text] [Related]
17. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption.
Minagawa M; Deng Q; Liu ZX; Tsukamoto H; Dennert G
Gastroenterology; 2004 May; 126(5):1387-99. PubMed ID: 15131799
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide augments aflatoxin B(1)-induced liver injury through neutrophil-dependent and -independent mechanisms.
Barton CC; Ganey PE; Roth RA
Toxicol Sci; 2000 Nov; 58(1):208-15. PubMed ID: 11053557
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
20. The platelet activating factor as a pivotal mediator of shock after liver ischemia.
Fukuoka T; Nakajima Y; Nakano H
Surg Today; 1995; 25(4):351-6. PubMed ID: 7633127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
